1
|
Parker SH, Lovin JD, Jobe WE, Burke BJ,
Hopper KD and Yakes WF: Nonpalpable breast lesions: stereotactic
automated large-core biopsies. Radiology. 180:403–407. 1991.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Parker SH, Lovin JD, Jobe WE, et al:
Stereotactic breast biopsy with a biopsy gun. Radiology.
176:741–747. 1990. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ioffe O, Berg WA and Silverberg SG:
Analysis of papillary lesions diagnosed on core needle biopsy:
management implications. Mod Pathol. 13:23A2000.
|
4
|
Philpotts LE, Shaheen NA, Jain KS, Carter
D and Lee CH: Uncommon high risk lesions of the breast diagnosed at
stereotactic core-needle biopsy: clinical importance. Radiology.
216:831–837. 2000. View Article : Google Scholar : PubMed/NCBI
|
5
|
Liberman L: Clinical management issues in
percutaneous core breast biopsy. Radiol Clin North Am. 38:791–807.
2000. View Article : Google Scholar : PubMed/NCBI
|
6
|
Mercado CL, Hamele-Bena D, Singer C, et
al: Papillary lesions of the breast: evaluation with stereotactic
directional vacuum-assisted biopsy. Radiology. 221:650–655. 2001.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Rosen EL, Bentley RC, Baker JA and Soo MS:
Imaging-guided core needle biopsy of papillary lesions of the
breast. AJR Am J Roentgenol. 179:1185–1192. 2002. View Article : Google Scholar : PubMed/NCBI
|
8
|
Irfan K and Brem RF: Surgical and
mammographic follow-up of papillary lesions and atypical lobular
hyperplasia diagnosed with stereotactic vacuum-assisted biopsy.
Breast J. 8:230–233. 2002. View Article : Google Scholar
|
9
|
Ivan D, Selinko V, Sahin AA, Sneige N and
Middleton LP: Accuracy of core needle biopsy diagnosis in assessing
papillary breast lesions: histologic predictors of malignancy. Mod
Pathol. 17:165–171. 2004. View Article : Google Scholar : PubMed/NCBI
|
10
|
Puglisi F, Zuiani C, Bazzocchi M, et al:
Role of mammography, ultrasound and large core biopsy in the
diagnostic evaluation of papillary breast lesions. Oncology.
65:311–315. 2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Agoff SN and Lawton TJ: Papillary lesions
of the breast with and without atypical ductal hyperplasia: can we
accurately predict benign behavior from core needle biopsy? Am J
Clin Pathol. 122:440–443. 2004. View Article : Google Scholar : PubMed/NCBI
|
12
|
Renshaw AA, Derhagopian RP, Tizol-Blanco
DM and Gould EW: Papillomas and atypical papillomas in breast core
needle biopsy specimens: risk of carcinoma in subsequent excision.
Am J Clin Pathol. 122:217–221. 2004. View Article : Google Scholar : PubMed/NCBI
|
13
|
Gendler LS, Feldman SM, Balassanian R, et
al: Association of breast cancer with papillary lesions identified
at percutaneous image-guided breast biopsy. Am J Surg. 188:365–370.
2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Carder PJ, Garvican J, Haigh I and Liston
JC: Needle core biopsy can reliably distinguish between benign and
malignant papillary lesions of the breast. Histopathology.
46:320–327. 2005. View Article : Google Scholar : PubMed/NCBI
|
15
|
Liberman L, Tornos C, Huzjan R, Bartella
L, Morris EA and Dershaw DD: Is surgical excision warranted after
benign, concordant diagnosis of papilloma at percutaneous breast
biopsy? AJR Am J Roentgenol. 186:1328–1334. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Mercado CL, Hamele-Bena D, Oken SM, Singer
CI and Cangiarella J: Papillary lesions of the breast at
percutaneous core-needle biopsy. Radiology. 238:801–808. 2006.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Valdes EK, Tartter PI, Genelus-Dominique
E, Guilbaud DA, Rosenbaum-Smith S and Estabrook A: Significance of
papillary lesions at percutaneous breast biopsy. Ann Surg Oncol.
13:480–482. 2006. View Article : Google Scholar : PubMed/NCBI
|
18
|
Plantade R, Gerard F and Hammou JC:
[Management of non-malignant papillary lesions diagnosed on
percutaneous biopsy]. J Radiol. 87:299–305. 2006.(In French).
|
19
|
Skandarajah AR, Field L, Yuen Larn Mou A,
et al: Benign papilloma on core biopsy requires surgical excision.
Ann Surg Oncol. 15:2272–2277. 2008. View Article : Google Scholar : PubMed/NCBI
|
20
|
Arora N, Hill C, Hoda SA, Rosenblatt R,
Pigalarga R and Tousimis EA: Clinicopathologic features of
papillary lesions on core needle biopsy of the breast predictive of
malignancy. Am J Surg. 194:444–449. 2007. View Article : Google Scholar : PubMed/NCBI
|
21
|
Sydnor MK, Wilson JD, Hijaz TA, Massey HD
and Shaw de Paredes ES: Underestimation of the presence of breast
carcinoma in papillary lesions initially diagnosed at core-needle
biopsy. Radiology. 242:58–62. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ashkenazi I, Ferrer K, Sekosan M, et al:
Papillary lesions of the breast discovered on percutaneous large
core and vacuum-assisted biopsies: reliability of clinical and
pathological parameters in identifying benign lesions. Am J Surg.
194:183–188. 2007. View Article : Google Scholar
|
23
|
Saddik M and Lai R: CD44s as a surrogate
marker for distinguishing intraductal papilloma from papillary
carcinoma of the breast. J Clin Pathol. 52:862–864. 1999.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Tan PH, Aw MY, Yip G, et al: Cytokeratins
in papillary lesions of the breast: is there a role in
distinguishing intraductal papilloma from papillary ductal
carcinoma in situ? Am J Surg Pathol. 29:625–632. 2005. View Article : Google Scholar : PubMed/NCBI
|
25
|
Shah VI, Flowers CI, Douglas-Jones AG,
Dallimore NS and Rashid M: Immunohistochemistry increases the
accuracy of diagnosis of benign papillary lesions in breast core
needle biopsy specimens. Histopathology. 48:683–691. 2006.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Moriya T, Kanomata N, Kozuka Y, et al:
Usefulness of immunohistochemistry for differential diagnosis
between benign and malignant breast lesions. Breast Cancer.
16:173–178. 2009. View Article : Google Scholar : PubMed/NCBI
|